Show simple item record

Superficial sarcomas with CIC rearrangement are aggressive neoplasms: A series of eight cases

dc.contributor.authorKo, Jennifer S.
dc.contributor.authorMarusic, Zlatko
dc.contributor.authorAzzato, Elizabeth M.
dc.contributor.authorFarkas, Daniel H.
dc.contributor.authorVan Arnam, John
dc.contributor.authorSeiwerth, Sven
dc.contributor.authorFritchie, Karen
dc.contributor.authorPatel, Rajiv M.
dc.contributor.authorRubin, Brian P.
dc.contributor.authorBillings, Steven D.
dc.date.accessioned2020-06-03T15:23:09Z
dc.date.availableWITHHELD_13_MONTHS
dc.date.available2020-06-03T15:23:09Z
dc.date.issued2020-06
dc.identifier.citationKo, Jennifer S.; Marusic, Zlatko; Azzato, Elizabeth M.; Farkas, Daniel H.; Van Arnam, John; Seiwerth, Sven; Fritchie, Karen; Patel, Rajiv M.; Rubin, Brian P.; Billings, Steven D. (2020). "Superficial sarcomas with CIC rearrangement are aggressive neoplasms: A series of eight cases." Journal of Cutaneous Pathology 47(6): 509-516.
dc.identifier.issn0303-6987
dc.identifier.issn1600-0560
dc.identifier.urihttps://hdl.handle.net/2027.42/155498
dc.description.abstractCIC rearranged sarcomas have significant overlap with Ewing sarcoma, are aggressive, and typically present in deep soft tissue. They most commonly have a t(4;19)(q35;q13) with CIC‐DUX4 fusion. Superficial presentation is rare. We report eight (6F, 2M; median 45‐years‐old, range 14‐65) superficial CIC‐rearranged sarcomas, involving the extremities (n = 4), vulva (n = 2), and trunk (n = 2). The tumors were composed of nodules/sheets of round cells with necrosis and hemorrhage separated by dense hyaline bands. Tumor cells had vesicular chromatin, prominent nucleoli and frequent mitotic figures. One showed pagetoid spread. Targeted next‐generation sequencing was positive for CIC‐DUX4 fusion (6/6); fluorescence in situ hybridization (FISH) was positive for CIC rearrangement (2/3). Eight of eight had evidence of CIC‐DUX4 fusion/rearrangement by molecular techniques. Immunohistochemistry was positive for CD99+ (8/8) and DUX4+ (4/4). FISH for EWSR1 rearrangement was negative (5/5). Of five patients with at least 6 months follow‐up, three of five died of disease, all within 2 years of presentation. One is alive with disease at 48 months. One is disease free at 3 months. Superficial CIC‐rearranged sarcomas should be considered in cases exhibiting features reminiscent of Ewing sarcoma, but with increased pleomorphism and/or geographic necrosis. In contrast to superficial Ewing sarcomas, superficial CIC‐rearranged sarcomas are aggressive.
dc.publisherBlackwell Publishing Ltd.
dc.publisherWiley Periodicals, Inc.
dc.subject.otherCIC
dc.subject.otherCIC‐DUX4
dc.subject.othercutaneous
dc.subject.otherEwing sarcoma
dc.subject.otherround cell sarcoma
dc.subject.othersarcoma
dc.subject.othersuperficial
dc.titleSuperficial sarcomas with CIC rearrangement are aggressive neoplasms: A series of eight cases
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelDermatology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/155498/1/cup13656.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/155498/2/cup13656_am.pdf
dc.identifier.doi10.1111/cup.13656
dc.identifier.sourceJournal of Cutaneous Pathology
dc.identifier.citedreferenceMaloney N, Smith SM, Peters SB, et al. Expanding the differential of superficial tumors with round‐cell morphology: Report of three cases of CIC‐rearranged sarcoma, a potentially under‐recognized entity [published online ahead of print, 2019 Dec 30]. J Cutan Pathol. 2020; 1 ‐ 6. https://doi.org/10.1111/cup.13639.
dc.identifier.citedreferenceCalonje JE, Brenn T, Lazar AJ, Billings SD. McKee’s Pathology of the Skin. Fifth ed. London, UK: Elsevier; 2020.
dc.identifier.citedreferenceShing DC, McMullan DJ, Roberts P, et al. FUS/ERG gene fusions in Ewing’s tumors. Cancer Res. 2003; 63 ( 15 ): 4568 ‐ 4576.
dc.identifier.citedreferenceKawamura‐Saito M, Yamazaki Y, Kaneko K, et al. Fusion between CIC and DUX4 up‐regulates PEA3 family genes in Ewing‐like sarcomas with t(4;19)(q35;q13) translocation. Hum Mol Genet. 2006; 15 ( 13 ): 2125 ‐ 2137.
dc.identifier.citedreferenceYoshimoto M, Graham C, Chilton‐MacNeill S, et al. Detailed cytogenetic and array analysis of pediatric primitive sarcomas reveals a recurrent CIC‐DUX4 fusion gene event. Cancer Genet Cytogenet. 2009; 195 ( 1 ): 1 ‐ 11. https://doi.org/10.1016/j.cancergencyto.2009.06.015 Erratum in: Cancer Genet Cytogenet. 2010 Feb;197(1):99.
dc.identifier.citedreferenceGraham CI, Chilton‐MacNeill S, Zielenska M, Somers GR. The CIC‐DUX4 fusion transcript is present in a subgroup of pediatric primitive round cell sarcomas. Hum Pathol. 2012; 43 ( 2 ): 180 ‐ 189. https://doi.org/10.1016/j.humpath.2011.04.023.
dc.identifier.citedreferencePierron G, Tirode F, Lucchesi C, et al. A new subtype of bone sarcoma defined by BCOR‐CCNB3 gene fusion. Nat Genet. 2012; 44 ( 4 ): 461 ‐ 466.
dc.identifier.citedreferenceSpecht K, Zhang L, Sung YS, et al. Novel BCOR‐MAML3 and ZC3H7B‐BCOR gene fusions in undifferentiated small blue round cell sarcomas. Am J Surg Pathol. 2016; 40 ( 4 ): 433 ‐ 442.
dc.identifier.citedreferenceItaliano A, Sung YS, Zhang L, et al. High prevalence of CIC fusion with double‐homeobox (DUX4) transcription factors in EWSR1‐negative undifferentiated small blue round cell sarcomas. Genes Chromosomes Cancer. 2012; 51 ( 3 ): 207 ‐ 218.
dc.identifier.citedreferenceSugita S, Arai Y, Aoyama T, et al. NUTM2A‐CIC fusion small round cell sarcoma: a genetically distinct variant of CIC‐rearranged sarcoma. Hum Pathol. 2017; 65: 225 ‐ 230.
dc.identifier.citedreferenceMachado I, Navarro L, Pellin A, et al. Defining Ewing and Ewing‐like small round cell tumors (SRCT): The need for molecular techniques in their categorization and differential diagnosis. A study of 200 cases. Ann Diagn Pathol. 2016; 22: 25 ‐ 32.
dc.identifier.citedreferenceSpecht K, Sung YS, Zhang L, Richter GH, Fletcher CD, Antonescu CR. Distinct transcriptional signature and immunoprofile of CIC‐DUX4 fusion‐positive round cell tumors compared to EWSR1‐rearranged Ewing sarcomas: further evidence toward distinct pathologic entities. Genes Chromosomes Cancer. 2014; 53 ( 7 ): 622 ‐ 633. https://doi.org/10.1002/gcc.22172.
dc.identifier.citedreferenceAntonescu CR, Owosho AA, Zhang L, et al. Sarcomas With CIC‐rearrangements are a distinct pathologic entity with aggressive outcome: a clinicopathologic and molecular study of 115 cases. Am J Surg Pathol. 2017; 41 ( 7 ): 941 ‐ 949.
dc.identifier.citedreferenceChoi EY, Thomas DG, McHugh JB, et al. Undifferentiated small round cell sarcoma with t(4;19)(q35;q13.1) CIC‐DUX4 fusion: a novel highly aggressive soft tissue tumor with distinctive histopathology. Am J Surg Pathol. 2013; 37 ( 9 ): 1379 ‐ 1386. https://doi.org/10.1097/PAS.0b013e318297a57d.
dc.identifier.citedreferenceSmith SC, Buehler D, Choi EY, et al. CIC‐DUX sarcomas demonstrate frequent MYC amplification and ETS‐family transcription factor expression. Mod Pathol. 2015; 28 ( 1 ): 57 ‐ 68.
dc.identifier.citedreferenceLehane F, Tsikleas G, Bettington A, Limarporn K, Wilkinson L, Lehane K. “Cyst” on the forearm of a 28‐year‐old female: case report of a CIC‐rearranged sarcoma. J Cutan Pathol. 2019; 46 ( 8 ): 599 ‐ 602. https://doi.org/10.1111/cup.13478.
dc.identifier.citedreferenceFletcher C, Bridge JA, Hogendoorn PC, et al. WHO Classification of Tumours of Soft Tissue and Bone. Lyon, France: IARC; 2013.
dc.identifier.citedreferenceCollier AB 3rd, Simpson L, Monteleone P. Cutaneous Ewing sarcoma: report of 2 cases and literature review of presentation, treatment, and outcome of 76 other reported cases. J Pediatr Hematol Oncol. 2011; 33 ( 8 ): 631 ‐ 634.
dc.identifier.citedreferenceYoshida A, Goto K, Kodaira M, et al. CIC‐rearranged sarcomas: a study of 20 cases and comparisons with Ewing sarcomas. Am J Surg Pathol. 2016; 40 ( 3 ): 313 ‐ 323.
dc.identifier.citedreferenceWang W‐L, Patel NR, Caragea M, et al. Expression of ERG, an Ets family transcription factor, identifies ERG‐rearranged Ewing sarcoma. Mod Pathol. 2012; 25 ( 10 ): 1378 ‐ 1383.
dc.identifier.citedreferenceSiegele B, Roberts J, Black JO, Rudzinski E, Vargas SO, Galambos C. DUX4 immunohistochemistry is a highly sensitive and specific marker for CIC‐DUX4 fusion‐positive round cell tumor. Am J Surg Pathol. 2017; 41 ( 3 ): 423 ‐ 429.
dc.identifier.citedreferenceYoshida A, Arai Y, Kobayashi E, et al. CIC break‐apart fluorescence in‐situ hybridization misses a subset of CIC‐DUX4 sarcomas: a clinicopathological and molecular study. Histopathology. 2017; 71 ( 3 ): 461 ‐ 469.
dc.identifier.citedreferenceKao YC, Sung YS, Chen CL, et al. ETV transcriptional upregulation is more reliable than RNA sequencing algorithms and FISH in diagnosing round cell sarcomas with CIC gene rearrangements. Genes Chromosomes Cancer. 2017; 56 ( 6 ): 501 ‐ 510.
dc.identifier.citedreferenceHung YP, Fletcher CD, Hornick JL. Evaluation of ETV4 and WT1 expression in CIC‐rearranged sarcomas and histologic mimics. Mod Pathol. 2016; 29 ( 11 ): 1324 ‐ 1334.
dc.identifier.citedreferenceLe Guellec S, Velasco V, Pérot G, Watson S, Tirode F, Coindre JM. ETV4 is a useful marker for the diagnosis of CIC‐rearranged undifferentiated round‐cell sarcomas: a study of 127 cases including mimicking lesions. Mod Pathol. 2016; 29 ( 12 ): 1523 ‐ 1531.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.